These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1358441)

  • 21. The c-erbA alpha-encoded thyroid hormone receptor is phosphorylated in its amino terminal domain by casein kinase II.
    Glineur C; Bailly M; Ghysdael J
    Oncogene; 1989 Oct; 4(10):1247-54. PubMed ID: 2552374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
    Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M
    Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
    Zenke M; Muñoz A; Sap J; Vennström B; Beug H
    Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The carbonic anhydrase II gene, a gene regulated by thyroid hormone and erythropoietin, is repressed by the v-erbA oncogene in erythrocytic cells.
    Pain B; Melet F; Jurdic P; Samarut J
    New Biol; 1990 Mar; 2(3):284-94. PubMed ID: 2126201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
    Urnov FD; Yee J; Sachs L; Collingwood TN; Bauer A; Beug H; Shi YB; Wolffe AP
    EMBO J; 2000 Aug; 19(15):4074-90. PubMed ID: 10921888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bicistronic retroviral vector reveals capacity of v-erbA to induce erythroleukemia and to co-operate with v-myb.
    Casini T; Graf T
    Oncogene; 1995 Sep; 11(6):1019-26. PubMed ID: 7566959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
    Andersson ML; Vennström B
    Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S
    Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The v-erbA oncogene (review).
    Thormeyer D; Baniahmad A
    Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythroid regulatory elements.
    Raich N; Romeo PH
    Stem Cells; 1993 Mar; 11(2):95-104. PubMed ID: 8096156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The v-ski oncogene cooperates with the v-sea oncogene in erythroid transformation by blocking erythroid differentiation.
    Larsen J; Beug H; Hayman MJ
    Oncogene; 1992 Oct; 7(10):1903-11. PubMed ID: 1408132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. v-erbA acts on retinoic acid receptors in immature avian erythroid cells.
    Sande S; Sharif M; Chen H; Privalsky M
    J Virol; 1993 Feb; 67(2):1067-74. PubMed ID: 8093487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes.
    Nagl SB; Bunn CF; Allison LA
    J Cell Biochem; 1997 Nov; 67(2):184-200. PubMed ID: 9328824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGF promotes in vivo tumorigenic growth of primary chicken embryo fibroblasts expressing v-myc and enhances in vitro transformation by the v-erbA oncogene.
    Khazaie K; Panayotou G; Aguzzi A; Samarut J; Gazzolo L; Jurdic P
    Oncogene; 1991 Jan; 6(1):21-8. PubMed ID: 1671532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NeP1. A ubiquitous transcription factor synergizes with v-ERBA in transcriptional silencing.
    Köhne AC; Baniahmad A; Renkawitz R
    J Mol Biol; 1993 Aug; 232(3):747-55. PubMed ID: 8102652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The v-erbA oncogene selectively inhibits iodide uptake in rat thyroid cells.
    Trapasso F; Martelli ML; Battaglia C; Angotti E; Mele E; Stella A; Samarut J; Avvedimento VE; Fusco A
    Oncogene; 1996 May; 12(9):1879-88. PubMed ID: 8649848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The v-erbA oncogene blocks expression of alpha2/beta1 integrin a normal inhibitor of erythroid progenitor proliferation.
    Mey A; Gandrillon O; McNagny KM; Clegg DO; Samarut J
    Oncogene; 2002 Apr; 21(18):2864-72. PubMed ID: 11973646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.
    Fuerstenberg S; Leitner I; Schroeder C; Schwarz H; Vennström B; Beug H
    EMBO J; 1992 Sep; 11(9):3355-65. PubMed ID: 1354613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action.
    Sharif M; Privalsky ML
    Cell; 1991 Sep; 66(5):885-93. PubMed ID: 1679679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.